Literature DB >> 17671248

Whole-genome analysis of sporadic amyotrophic lateral sclerosis.

Travis Dunckley1, Matthew J Huentelman, David W Craig, John V Pearson, Szabolcs Szelinger, Keta Joshipura, Rebecca F Halperin, Chelsea Stamper, Kendall R Jensen, David Letizia, Sharon E Hesterlee, Alan Pestronk, Todd Levine, Tulio Bertorini, Michael C Graves, Tahseen Mozaffar, Carlayne E Jackson, Peter Bosch, April McVey, Arthur Dick, Richard Barohn, Catherine Lomen-Hoerth, Jeffrey Rosenfeld, Daniel T O'connor, Kuixing Zhang, Richard Crook, Henrik Ryberg, Michael Hutton, Jonathan Katz, Ericka P Simpson, Hiroshi Mitsumoto, Robert Bowser, Robert G Miller, Stanley H Appel, Dietrich A Stephan.   

Abstract

BACKGROUND: Approximately 90% of persons with amyotrophic lateral sclerosis (ALS) have the sporadic form, which may be caused by the interaction of multiple environmental factors and previously unknown genes.
METHODS: We performed a genomewide association analysis using 766,955 single-nucleotide polymorphisms (SNPs) found in 386 white patients with sporadic ALS and 542 neurologically normal white controls (the discovery series). Associations of SNPs with sporadic ALS were confirmed in two independent replication populations: replication series 1, with 766 case patients with the disease and 750 neurologically normal controls, and replication series 2, with 135 case patients and 275 controls.
RESULTS: We identified 10 genetic loci that are significantly associated (P<0.05) with sporadic ALS in three independent series of case patients and controls and an additional 41 loci that had significant associations in two of the three series. The most significant association with disease in white case patients as compared with controls was found for a SNP near an uncharacterized gene known as FLJ10986 (P=3.0x10(-4); odds ratio for having the genotype in patients vs. controls, 1.35; 95% confidence interval, 1.13 to 1.62). The FLJ10986 protein was found to be expressed in the spinal cord and cerebrospinal fluid of patients and of controls. Specific SNPs seem to be associated with sex, age at onset, and site of onset of sporadic ALS.
CONCLUSIONS: Variants of FLJ10986 may confer susceptibility to sporadic ALS. FLJ10986 and 50 other candidate loci warrant further investigation for their potential role in conferring susceptibility to the disease. Copyright 2007 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671248     DOI: 10.1056/NEJMoa070174

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  92 in total

1.  Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity.

Authors:  Qiang Li; Netanya Y Spencer; Nicholas J Pantazis; John F Engelhardt
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

2.  Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia.

Authors:  Alice Hadchouel; Xavier Durrmeyer; Emmanuelle Bouzigon; Roberto Incitti; Johanna Huusko; Pierre-Henri Jarreau; Richard Lenclen; Florence Demenais; Marie-Laure Franco-Montoya; Inès Layouni; Juliana Patkai; Jacques Bourbon; Mikko Hallman; Claude Danan; Christophe Delacourt
Journal:  Am J Respir Crit Care Med       Date:  2011-08-11       Impact factor: 21.405

Review 3.  Diagnosis and management of motor neurone disease.

Authors:  Christopher J McDermott; Pamela J Shaw
Journal:  BMJ       Date:  2008-03-22

Review 4.  Redox modifier genes and pathways in amyotrophic lateral sclerosis.

Authors:  Barrie J Carter; Pervin Anklesaria; Stephanie Choi; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

5.  Genome-wide association studies in amyotrophic lateral sclerosis.

Authors:  Nicolas Dupré; Paul Valdmanis
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

6.  FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases.

Authors:  Jelena Mojsilovic-Petrovic; Natalia Nedelsky; Marco Boccitto; Itzhak Mano; Savvas N Georgiades; Weiguo Zhou; Yuhong Liu; Rachael L Neve; J Paul Taylor; Monica Driscoll; Jon Clardy; Diane Merry; Robert G Kalb
Journal:  J Neurosci       Date:  2009-06-24       Impact factor: 6.167

7.  MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice.

Authors:  Andrew H Williams; Gregorio Valdez; Viviana Moresi; Xiaoxia Qi; John McAnally; Jeffrey L Elliott; Rhonda Bassel-Duby; Joshua R Sanes; Eric N Olson
Journal:  Science       Date:  2009-12-11       Impact factor: 47.728

Review 8.  Progress toward the clinical application of patient-specific pluripotent stem cells.

Authors:  Evangelos Kiskinis; Kevin Eggan
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

9.  Screening for replication of genome-wide SNP associations in sporadic ALS.

Authors:  Simon Cronin; Barbara Tomik; Daniel G Bradley; Agnieszka Slowik; Orla Hardiman
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

10.  Phenotypic variability of patients homozygous for the GJB2 mutation 35delG cannot be explained by the influence of one major modifier gene.

Authors:  Nele Hilgert; Matthew J Huentelman; Ashley Q Thorburn; Erik Fransen; Nele Dieltjens; Malgorzata Mueller-Malesinska; Agnieszka Pollak; Agata Skorka; Jaroslaw Waligora; Rafal Ploski; Pierangela Castorina; Paola Primignani; Umberto Ambrosetti; Alessandra Murgia; Eva Orzan; Arti Pandya; Kathleen Arnos; Virginia Norris; Pavel Seeman; Petr Janousek; Delphine Feldmann; Sandrine Marlin; Françoise Denoyelle; Carla J Nishimura; Andreas Janecke; Doris Nekahm-Heis; Alessandro Martini; Elena Mennucci; Timea Tóth; Istvan Sziklai; Ignacio Del Castillo; Felipe Moreno; Michael B Petersen; Vasiliki Iliadou; Mustafa Tekin; Armagan Incesulu; Ewa Nowakowska; Jerzy Bal; Paul Van de Heyning; Anne-Françoise Roux; Catherine Blanchet; Cyril Goizet; Guenaëlle Lancelot; Graça Fialho; Helena Caria; Xue Zhong Liu; Ouyang Xiaomei; Paul Govaerts; Karen Grønskov; Karianne Hostmark; Klemens Frei; Ingeborg Dhooge; Stephen Vlaeminck; Erdmute Kunstmann; Lut Van Laer; Richard J H Smith; Guy Van Camp
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.